Blanket Purchase Agreement 36F79721D0019-36C24123A0032
Award Date
2/7/23
Last Date to Order
1/31/28
Federal Agency
Veterans Integrated Service Network 1
Awardee
Veracyte Labs SD Corporation
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 8 awarded a $972,177 Blanket Purchase Agreement (BPA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., to provide Decipher Prostate Cancer genomic testing services. This single-award IDV contract, utilizing the GSA Medical Laboratory Testing and Analysis Services Schedule, enables VISN 8 facilities to efficiently access Decipher's proprietary molecular diagnostic tests to support...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) contract to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the provision of Decipher Prostate Cancer Testing services. This contract, valued at up to $991,815.95, is established under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not have a set-aside designation. The contract aims to support the VA's efforts to provide personalized,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery, indefinite quantity contract to Veracyte Labs SD Corp, a division of Decipher Biosciences, Inc., with a potential value of $249,000.00 and a period of performance through September 30, 2023. Against this contract, the agency issued four firm fixed price delivery orders for prostate cancer testing services. The orders called for providing the proprietary...
The key products and services being delivered under this federal contract IDV award are specialized genomic testing services, primarily focused on prostate cancer diagnostics and treatment planning. The prime contractor, Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., provides its proprietary Decipher Prostate Cancer Test and other advanced molecular diagnostic capabilities to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Networks (VISNs)...
The federal contract IDV award is for Decipher Prostate Genomic Classifier testing services provided by Veracyte Labs SD Corporation, a division of Veracyte, Inc., to the Department of Veterans Affairs (VA). The single-award Indefinite Delivery Contract has a ceiling value of $194,435.40 and a period of performance through September 30, 2026. Under this IDV, Veracyte will deliver task orders for Decipher Prostate Cancer testing to support the VA's efforts to provide personalized cancer care...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 22 awarded a single-award Blanket Purchase Agreement (BPA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype genetic testing services. The BPA has a ceiling value of $970,352 and a period of performance from February 2023 through February 2028. Under this IDV, the VA can order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis at...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Mdxhealth, Inc., a for-profit healthcare company, for the provision of specialized cancer diagnostic testing services. The BPA is under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract (FSS-621-II) and has a total potential value of $280,000 with an ultimate completion date of April 2, 2029. Specifically, the BPA covers DX Prostate Testing,...
This indefinite delivery contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a for-profit medical diagnostics company. The contract, which is not set aside for any specific business category, has a ceiling value of $2,000,000 and an ultimate completion date of April 30, 2028. Under this contract, Veracyte will provide reference laboratory services, including specialized genomic testing and classifier services, to support...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded Myriad Genetic Laboratories Inc. a blanket purchase agreement to provide Prolaris prostate cancer testing services. Three firm fixed price call contracts were placed against the BPA between 2021 and 2024, with a combined value of $74,970. As the prime, Myriad will deliver the genomic testing to the VA Salt Lake City Health Care System in Utah. This testing assists with disease risk...
The federal contract IDV award to Veracyte, Inc. under the GSA's Medical Laboratory Testing and Analysis Services Schedule (FSS-621-II) enables multiple federal agencies, including the Department of Veterans Affairs (VA) and Defense Health Agency, to procure Veracyte's genomic testing services. The contract, valued at up to $2.3 million through July 2028, provides access to Veracyte's commercial laboratory capabilities for cancer screening and diagnosis, such as the Afirma Genomic Sequencing...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
BPA Call 36C24123A0032-36C24125N0488 | Veracyte Labs SD Corporation | $300.0k | 2/1/25 | 1/31/26 | 1/30/25 | |
BPA Call 36C24123A0032-36C24123N0206 | Veracyte Labs SD Corporation | $294.9k | 2/7/23 | 1/31/24 | 1/8/25 | |
BPA Call 36C24123A0032-36C24124N0346 | Veracyte Labs SD Corporation | $139.6k | 2/1/24 | 1/31/25 | 7/8/25 |